News
FORA
2.700
+0.37%
0.010
Ametek (AME) Q1 Earnings Surpass Estimates
NASDAQ · 3d ago
CGI Group (GIB) Tops Q2 Earnings Estimates
NASDAQ · 4d ago
Strength Seen in Perficient (PRFT): Can Its 8.7% Jump Turn into More Strength?
NASDAQ · 5d ago
Weekly Report: what happened at FORA last week (0422-0426)?
Weekly Report · 6d ago
Weekly Report: what happened at FORA last week (0415-0419)?
Weekly Report · 04/22 12:26
Analysts Are Bullish on These Healthcare Stocks: TELA Bio (TELA), Petmed Express (PETS)
TipRanks · 04/15 13:30
Weekly Report: what happened at FORA last week (0408-0412)?
Weekly Report · 04/15 12:16
FORIAN INC. ANNOUNCES THE PASSING OF DIRECTOR MARTIN J. WYGOD
Reuters · 04/14 22:03
Press Release: Forian Inc. Announces the Passing of Director Martin J. Wygod
Forian Inc. Announces the Passing of Director Martin J. Wygod (Marty) at age 84. Marty was a healthcare entrepreneur, thoroughbred horse breeder and philanthropist. He is the father of Forian Executive Chairman, Chief Executive Officer and President, Max Wygod. Prior to Forian, Marty was the Chairman and CEO of WebMD Health Corp.
Dow Jones · 04/14 22:03
Weekly Report: what happened at FORA last week (0401-0405)?
Weekly Report · 04/08 12:21
Forian Price Target Maintained With a $5.00/Share by Roth MKM
Dow Jones · 04/04 14:12
Roth MKM Reiterates Buy on Forian, Maintains $5 Price Target
Benzinga · 04/04 14:02
Analysts Offer Insights on Healthcare Companies: Forian (FORA), Achieve Life Sciences (ACHV) and P3 Health Partners (PIII)
TipRanks · 04/01 13:00
Weekly Report: what happened at FORA last week (0325-0329)?
Weekly Report · 04/01 12:18
FORA Stock Earnings: Forian Beats EPS, Misses Revenue for Q4 2023
Forian just reported results for the fourth quarter of 2023. Forian reported earnings per share of -1 cent. The company reported revenue of $5.37 million. This was 3.44% worse than the analyst estimate for revenue in the same period of time.
Investorplace · 03/29 00:53
Press Release: Forian Inc. Announces Fourth Quarter and Full Year 2023 Financial Results
Forian Inc. Announces Fourth Quarter and Full Year 2023 Revenue Grew 25% Full year 2023 Adjusted EBITDA of $2.3MM. Forian is a provider of data science driven information and analytics solutions to the healthcare and life sciences industries.
Dow Jones · 03/28 20:06
Press Release: Forian Inc. Announces Fourth -3-
Net cash used in operating operations: Cash from sale of securities and cash used to pay employee taxes. Cash used in investing activities: Cash used to buy and sell stock. Cash flows used to fund investments: Cash paid to employees to redeem stock and convertible notes. Net cash provided by cash flows to and from the company: Net cash used by the company to fund operations.
Dow Jones · 03/28 20:06
After-Hours Earnings Report for March 28, 2024 : ACHV, ACNT, AREC, AXDX, CPTN, CURV, DARE, DNMR, DYAI, FORA, HSDT, INLX
NASDAQ · 03/28 18:00
Earnings Scheduled For March 28, 2024
Universal Stainless is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million. Walgreens Boots Alliance is likely to report earnings for its fourth quarter. Companies Reporting Before The Bell include Shimmick and Universal Stainless. Companies reporting after the bell include INmune Bio and Oxford Industries.
Benzinga · 03/28 09:24
Earnings Outlook For Forian
Forian is set to give its latest quarterly earnings report on Thursday, 2024-03-28. Analysts estimate Forian will report an earnings per share of $-0.03. Last quarter the company beat EPS by $0.19. Shares of Forian were trading at $3.26 as of March 26.
Benzinga · 03/27 15:01
More
Webull provides a variety of real-time FORA stock news. You can receive the latest news about Forian Inc through multiple platforms. This information may help you make smarter investment decisions.
About FORA
Forian Inc. is a technology solutions company. The Company provides a suite of data management capabilities and data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer and provider segments. The Company’s operations consist of providing analytic and information services to the healthcare and related industries, which are all subscription and services-based solutions. The Company’s offerings include commercial, Real World Evidence (RWE) and market access solutions and data-driven insights to optimize the operational, clinical and financial performance of its customers. The Company provides its information solutions both as an enabling technology to consultants and service providers serving the healthcare and life sciences industries, as well as to end users in the healthcare and life sciences industries.